Autor: |
Eren, Z., Günal, M.Y., Bakir, E.A., Coban, J., Ça?layan, B., Ekimci, N., Kantarci, G. |
Přispěvatelé: |
Eren, Z., Günal, M.Y., Bakir, E.A., Coban, J., Ça?layan, B., Ekimci, N., Kantarci, G., Yeditepe Üniversitesi |
Jazyk: |
angličtina |
Rok vydání: |
2014 |
Předmět: |
|
Popis: |
Background/Aims: The aim of the present study was to investigate the effect of combination of aliskiren with paricalcitol on experimental diabetic nephropathy (DN) model in rats. Methods: Forty male Sprague Dawley rats were divided into 5 groups of 8 rats each, namely the control (Group C), diabetes (Group D), aliskiren (Group A), paricalcitol (Group P), and aliskiren plus paricalcitol (Group A+P) groups. Aliskiren was given by oral-gavage at a dose of 50 mg/kg/day once daily for 12 weeks. Paricalcitol was given by intraperitoneally at a dose of 0,4 µg/kg/three day of week for 12 weeks. Renal function parameters, oxidative stress biomarkers, mRNA expression of renin-angiotensin system parameters and kidney histology were determined. Results: Group A+P had lower mean albümin-to-creatinine ratio (ACR) (p=0.004) as well as higher creatinine clearance (CCr) (p |
Databáze: |
OpenAIRE |
Externí odkaz: |
|